Amarin Corp Plcuk AMRN
NASDAQ AMRN
$14.09 +0.03 (+0.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Amarin Corp Plcuk (AMRN) Short-term Investments (2020 - 2026)

Amarin Corp Plc\Uk (AMRN) posted quarterly Short-term Investments of $171.1 million for Q2 2026, up 13.44% year-over-year from $150.8 million in Q2 2025, and down 3.22% quarter-over-quarter from $176.8 million in Q1 2026.

Amarin Corp Plcuk (AMRN) Short-term Investments (2020 - 2026) Analysis & Trends

Amarin Corp Plc\Uk (AMRN) has reported Short-term Investments for 7 consecutive years, with $171.1 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Short-term Investments rose 13.44% year-over-year to $171.1 million; the TTM figure through Jun 2026 stood at $171.1 million (up 13.44% YoY), while the FY2025 annual figure was $167.9 million, down 3.03% from the prior year.
  • Short-term Investments retreated to $171.1 million in Q2 2026 per AMRN's latest filing, from $176.8 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $176.8 million in Q1 2026 and bottomed at $49.8 million in Q3 2023.
  • Historically, Short-term Investments has averaged $124.9 million across 5 years, with a median of $132.4 million in 2022.
  • Annual changes were most pronounced in 2022 — Short-term Investments tumbled 75.34% — and 2024, when it soared 198.51%.
  • Amarin Corp Plc\Uk's Short-term Investments stood at $91.7 million in 2022, then soared by 32.4% to $121.4 million in 2023, then soared by 42.65% to $173.2 million in 2024, then slipped by 3.03% to $167.9 million in 2025, then increased by 1.89% to $171.1 million in 2026.
  • Business Quant data shows AMRN's Short-term Investments at $171.1 million in Q2 2026, $176.8 million in Q1 2026, and $167.9 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Amarin Corp Plcuk 5.86 Bn 5.54 Bn 14.99 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 171.10 Mn
Mar 31, 2026 176.80 Mn
Dec 31, 2025 167.93 Mn
Sep 30, 2025 163.80 Mn
Jun 30, 2025 150.83 Mn
Mar 31, 2025 162.30 Mn
Dec 31, 2024 173.18 Mn
Sep 30, 2024 148.80 Mn
Jun 30, 2024 90.74 Mn
Mar 31, 2024 94.24 Mn
Dec 31, 2023 121.41 Mn
Sep 30, 2023 49.85 Mn
Jun 30, 2023 79.92 Mn
Mar 31, 2023 113.00 Mn
Dec 31, 2022 91.70 Mn
Sep 30, 2022 63.20 Mn
Jun 30, 2022 85.23 Mn
Mar 31, 2022 143.41 Mn
Dec 31, 2021 234.67 Mn
Sep 30, 2021 256.30 Mn